A new target to utero-relaxant drugs: the β3-adrenoceptor, predominant and resistant to desensitization in human myometrium at the end of pregnancy

被引：0

|

作者：

Rouget, C. ^{[1
]}

Breuiller-Fouche, M. ^{[2
]}

Leroy, M. J. ^{[2
]}

Cabrol, D. ^{[2
]}

Loustalot, C. ^{[3
]}

Croci, T. ^{[4
]}

Morcillo, E. ^{[1
]}

Sagot, P. ^{[3
]}

Advenier, C. ^{[1
]}

Bardou, M. ^{[1
]}

机构：

[1] UFR Biomed Sts Peres, UPRES EA220, Paris, France

[2] INSERM, U427, Paris, France

[3] CHU Bocage, Dept Gynaecol, Dijon, France

[4] Res Ctr Sanofi Midy, Milan, Italy

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2004年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：38 / 38

页数：1

相关论文

共 3 条

[1] β3-adrenoceptor is the predominant β-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy
Rouget, C
Bardou, M
Breuiller-Fouché, M
Loustalot, C
Qi, H
Naline, E
Croci, T
Cabrol, D
Advenier, C
Leroy, MJ
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1644 - 1650
[2] Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors
Oger, S
Méhats, C
Barnette, MS
Ferré, F
Cabrol, D
Leroy, MJ
BIOLOGY OF REPRODUCTION, 2004, 70 (02) : 458 - 464
[3] Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium:: Consequences for the utero-relaxant effect of PDE4-selective inhibitors
Méhats, C
Tanguy, G
Paris, B
Robert, B
Pernin, N
Ferré, F
Leroy, MJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 292 (02): : 817 - 823